Shanghai Conant Optical Co., Ltd. Annual Report 2025: Key Highlights and Investor Insights

Introduction

Shanghai Conant Optical Co., Ltd., a leading provider of optical resin spectacle lenses, has released its Annual Report for the year ended 31 December 2025. This comprehensive report offers a detailed overview of the company’s financial performance, corporate developments, and strategic initiatives that could have significant implications for shareholders and market participants.

Financial Performance

• Revenue Growth: The Group achieved a record revenue of RMB 2,185,970,000 in 2025, up 6.1% from 2024, marking five consecutive years of revenue growth.
• Profitability: Gross profit reached RMB 917,458,000 (15.4% increase), while profit before tax surged to RMB 638,115,000 (28.4% increase). Net profit for 2025 was RMB 557,723,000 (30.2% increase).
• Balance Sheet Strength: Total assets soared to RMB 3,545,011,000 in 2025 (up 48.5% YoY), with net assets at RMB 2,743,249,000, reflecting robust financial health and capital expansion.
• Impairment Gains: Notably, impairment gains under the expected credit loss model increased by RMB 39.7 million, indicating improved recovery of trade receivables and better debtor credit status.

Dividend Policy and Shareholder Returns

• Final Dividend: The Board recommends a payment of RMB 0.20 (tax inclusive) per ordinary share for 2025. Combined with an interim dividend of RMB 0.15 per share, total dividends declared for the year amount to RMB 0.35 per share.
• Dividend Payment Schedule: Subject to AGM approval on 11 June 2026, the final dividend will be paid to shareholders registered on 24 June 2026, with expected distribution before 11 August 2026.
• Dividend Policy: The company does not have a fixed payout ratio. Future dividends depend on operational results, financial conditions, cash requirements, and PRC legal constraints, including statutory reserve requirements. Shareholders should note that dividend payments are subject to PRC GAAP or IFRS, whichever is lower.

Significant Investments and Asset Allocation

• Major Investment Activity: In 2025, the Group made substantial investments in financial assets at fair value through profit or loss (FVTPL), totaling RMB 788.5 million—more than 5% but less than 25% of total assets. These investments mainly comprise wealth management products from reputable PRC financial institutions and banks.
• Potential Price Sensitivity: The scale and nature of these investments could have an impact on asset yields and risk exposure, depending on market conditions.

Corporate Governance and Internal Controls

• Board Structure: Following amendments to the Articles of Association, the Board size increased to up to 12 directors, enhancing governance capacity.
• Compliance: The company maintained full compliance with the Corporate Governance Code (CG Code), except for a minor deviation from Code Provision C.2.1.
• Risk Management: The Risk Management Committee actively evaluated risks related to international sanctions, internal controls, and financial management. Two meetings were held in 2025 to monitor and improve risk policies.
• ESG Initiatives: The company established an ESG Committee and took steps to ensure environmental compliance, waste treatment, and hazardous waste management.

Share Capital and Share Awards

• Share Repurchases: Under the Employee Share Award Scheme, 2,189,000 H Shares were repurchased from the open market in 2025, with 12,356,160 H Shares held on trust platforms but not yet granted to employees.
• Equity-Settled Share-Based Payments: RMB 23.6 million was recognized as equity-settled share-based payment expense, reflecting ongoing employee incentive programs.
• Shareholder Structure: As of 31 December 2025, Mr. Fei, the chairman, held 212,740,030 H Shares, representing 44.33% of total share capital. Public float remains above the minimum 25% requirement.

Operational Highlights and Risks

• Customer Concentration: The top five customers accounted for 23.9% of total revenue, with the largest customer contributing 8.7%. Top five suppliers represented 45% of purchases, and the largest supplier 26%.
• Foreign Exchange Risk: With significant overseas sales denominated in USD, JPY, RMB, and EUR, the company faces currency risk. Active management via swaps and forward contracts is in place to mitigate exposures.
• Finance Costs: Finance costs dropped 39.7% to RMB 6.1 million, mainly due to optimized financing and lower bank loan interest.
• Legal Compliance: No material breaches or non-compliance with PRC laws were reported in 2025.

Use of IPO Proceeds

• IPO Proceeds Utilization: Out of HK\$473.5 million raised in the 2021 IPO, HK\$471.0 million (99.5%) has been allocated to expansion, R&D, sales and marketing, efficiency improvements, and debt repayment. Only HK\$2.5 million remains to be used, mainly for sales and marketing and production efficiency enhancements, expected to be spent by mid-2026.
• Delay in Sales and Marketing Spend: The delay is attributed to changes in business strategy driven by macroeconomic, social, and environmental factors in China.

Internal Controls and Audit

• Internal Control Effectiveness: Supervisors confirm that the internal control system is complete, effective, and compliant with legal and operational requirements. Deloitte Touche Tohmatsu issued an “unqualified opinion” on the audited consolidated financial statements.

Important Shareholder Matters and Price Sensitivity

• Dividend Increase: The recommended final dividend for 2025 is RMB 0.20 per share, up from RMB 0.16 in 2024, reflecting improved profitability and shareholder returns.
• Large-Scale Investments: The substantial allocation to wealth management products may affect asset returns and risk profile, depending on PRC market dynamics.
• Board Expansion: The increase in Board size may signal future strategic expansion or enhanced governance.
• Improved Credit and Impairment Recovery: The significant gain in impairment recovery may indicate stronger receivables management and improved customer creditworthiness.
• Share Repurchase and Award Scheme: Ongoing share repurchases for employee awards could influence share liquidity and price dynamics.

Disclaimer

This article is a summary and analysis based on Shanghai Conant Optical Co., Ltd.’s 2025 Annual Report. The information is provided for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult professional advisors before making investment decisions. The company’s performance, dividend policy, and investment strategies may be subject to change and are influenced by external market conditions and regulatory requirements.

View CONANT OPTICAL Historical chart here